CNMD today
$50.57+$0.09 (+0.18%)close Nov 13, 2026Trend
DailyUptrend (confirmed)
4 hourAscending Triangle
1 hourStrong Bearish
15 minDescending Triangle
5 minBullish
Daily trend turns down below $43.50
Key levels
Resistance$54.80
Resistance$52.02
Support$49.72
Support$47.18
Latest news & SEC filings
SEC FilingCONMED Corp filed an insider trading report (Form 4)
AnalystJP Morgan raises CONMED price target to $50
AnalystWells Fargo lifts CONMED price target after Q3 results
AnalystJP Morgan keeps Neutral rating on Conmed, lifts price target to $50
All CNMD news →About CONMED
CONMED develops and sells surgical devices and equipment used in operating rooms and other clinical settings. Its offerings include minimally invasive instruments, electrosurgical systems, and monitoring tools, with the AirSeal system among its notable products. The company serves hospitals, surgery centers, physicians, and other healthcare providers, and it operates internationally.
Based on the company's 10-K filed Feb 17, 2026.
NYSE · Healthcare
CONMED Corp (CNMD)
What Is the Price Target for CNMD?
SEPT Low Target
$37.82
SEPT Mid Target
$44.50
SEPT High Target
$51.17
Analyst Consensus
$44.50
Is CNMD a Buy or Sell Right Now?
Thesis
- •Revenue growing 5.2% YoY with STABLE trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CNMD.
Start Free Trial →Is CNMD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$57.57
39
Moat Score
NONE
6/9
Piotroski Score
1.9
Altman Z-Score
What Is Smart Money Doing with CNMD?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Foust Hollie K | officer | Buy | 4,000 | - | Nov 4, 2026 |
| Foust Hollie K | officer | Sale | 1,124 | $60K | Nov 4, 2026 |
| Bronson David M. | director | Buy | 668 | - | Jun 2, 2026 |
| Council LaVerne H | director | Buy | 668 | - | Jun 2, 2026 |
| Farkas Charles | director | Buy | 668 | - | Jun 2, 2026 |
| Kaye Mark | director | Buy | 668 | - | Jun 2, 2026 |
| Schwarzentraub Barbara J | director | Buy | 668 | - | Jun 2, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CNMD Growth Story
Revenue YoY
5.2%
3yr Revenue CAGR
9.6%
EPS Growth YoY
-64.47%
FCF Growth YoY
-1.9%
Revenue Trend
STABLE
Dark Pool Trades for CNMD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CNMD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:15 | $50.48 | 1,570 | $$79K | SELL |
| 20:45:33 | $50.38 | 1,400 | $$71K | BUY |
| 16:48:59 | $50.35 | 1,348 | $$68K | BUY |
| 16:48:58 | $50.40 | 1,348 | $$68K | BUY |
| 21:00:15 | $50.77 | 1,698 | $$86K | SELL |
5 dark pool trades shown · $$372K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for CONMED Corp (CNMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CNMD — frequently asked questions
What is CNMD stock price today?
CONMED Corp (CNMD) is at $50.57, up 0.18% (+$0.09) at the Nov 13, 2026 close.
Why is CNMD stock moving today?
Latest CNMD news — Nov 6, 2026: CONMED Corp filed an insider trading report (Form 4) · Oct 30, 2026: JP Morgan raises CONMED price target to $50
What is the CNMD price target?
The average analyst price target for CNMD is $44.50, ranging from $36 to $50, based on 6 analysts.
What do analysts rate CNMD?
Analyst ratings for CNMD: 0 Buy, 10 Hold, 1 Sell — consensus Hold.
Did CNMD beat earnings?
CNMD last reported on Oct 28, 2026: EPS $1.04 vs $1.00 expected — a beat of 4.0%.
What is CNMD's P/E ratio?
CNMD trades at a P/E of 21.5 vs a Healthcare average of 17.5.
Does CNMD pay a dividend?
Yes. CNMD's dividend yield is 1.96%.
What are CNMD support and resistance levels?
Support: $49.72, $47.18, $43.50. Resistance: $52.02, $54.80, $57.82.
What are insiders doing with CNMD?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on CNMD?
Nov 6, 2026: CONMED Corp filed an insider trading report (Form 4) · Oct 30, 2026: JP Morgan raises CONMED price target to $50 · Oct 29, 2026: Wells Fargo lifts CONMED price target after Q3 results